Cargando…
Cysteine cathepsin C: a novel potential biomarker for the diagnosis and prognosis of glioma
BACKGROUND: Cysteine cathepsin C encoded by the CTSC gene is an important member of the cysteine cathepsin family that plays a key role regulation of many types of tumors. However, whether CTSC is involved in the pathological process of glioma has not yet been reported. We comprehensively analyzed d...
Autores principales: | Cheng, Xingbo, Ren, Zhishuai, Liu, Zhendong, Sun, Xiang, Qian, Rongjun, Cao, Chen, Liu, Binfeng, Wang, Jialin, Wang, Hongbo, Guo, Yuqi, Gao, Yanzheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812029/ https://www.ncbi.nlm.nih.gov/pubmed/35109832 http://dx.doi.org/10.1186/s12935-021-02417-6 |
Ejemplares similares
-
ELK3: A New Molecular Marker for the Diagnosis and Prognosis of Glioma
por: Liu, Zhendong, et al.
Publicado: (2021) -
ITGB3BP is a potential biomarker associated with poor prognosis of glioma
por: Liu, Zhendong, et al.
Publicado: (2021) -
Interleukin-1 receptor-associated kinase 4 as a potential biomarker: Overexpression predicts poor prognosis in patients with glioma
por: Wang, Jialin, et al.
Publicado: (2021) -
GNG5 is a novel oncogene associated with cell migration, proliferation, and poor prognosis in glioma
por: Zhang, Wang, et al.
Publicado: (2021) -
High expression of HOXA4 in patients with glioma indicates unfavorable clinical outcomes
por: Yu, Zhenghong, et al.
Publicado: (2022)